Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Autolus Therapeutics Plc ADR (NQ: AUTL )

5.200 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 5.200
Bid (Size) 5.050 (2)
Ask (Size) 6.400 (1)
Prev. Close 5.200
Today's Range 5.200 - 5.200
52wk Range 5.070 - 17.19
Shares Outstanding 52,346,231
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Autolus Therapeutics Reports First Quarter 2021 Financial Results and Operational Progress
- Conference call to be held on May 6, 2021 at 8:30 am ET/1:30 pm BST - 
From GlobeNewswire News Releases
Autolus Therapeutics to Report First Quarter 2021 Financial Results and Host Conference Call on May 6
From GlobeNewswire News Releases

Performance

YTD
-44.44%
-44.44%
1 Month
-12.90%
-12.90%
3 Month
-31.22%
-31.22%
6 Month
-56.45%
-56.45%
1 Year
-47.32%
-47.32%

More News

Read More
Autolus Therapeutics Receives Innovation Passport and entry into ILAP for AUTO4 for the treatment of T cell receptor constant region beta chain 1 (TRBC1) positive T cell lymphomas
From GlobeNewswire News Releases
Autolus Therapeutics announces appointment of Martin Murphy as Non-executive Chairman
From GlobeNewswire News Releases
Autolus Therapeutics to Participate in Investor Conferences Through April
From GlobeNewswire News Releases
Autolus Therapeutics Receives PRIME designation for AUTO1 for the treatment of adult ALL
From GlobeNewswire News Releases
Autolus Therapeutics Announces Updated Manufacturing Facility Strategy Leveraging its UK Operations
From GlobeNewswire News Releases
Autolus Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Progress
From GlobeNewswire News Releases
Autolus Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference
From GlobeNewswire News Releases
Autolus Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional ADSs
From GlobeNewswire News Releases
Autolus Announces Pricing of Public Offering
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.